000			05407cam a2200613 i 4500
001			ocn872568714
003			OCoLC
005			20240729131529.0
006			m d
007			cr |||||||||||
008			130703s2013 nyu ob 001 0 eng
010			_a 2019713842
040			_aDLC _beng _erda _cDLC _dOCLCF _dAU@ _dSTF _dN$T
020			_a9781628085242 _qebook
020			_a162808524X
020			_z9781628085075 _qhardcover
020			_z162808507X
035			_a710361 _b(N$T)
035			_a(OCoLC)872568714
042			_apcc
072		7	_aHEA _x039000 _2bisacsh
072		7	_aMED _x014000 _2bisacsh
072		7	_aMED _x022000 _2bisacsh
072		7	_aMED _x112000 _2bisacsh
072		7	_aMED _x045000 _2bisacsh
049			_aMAIN
245	0	0	_aLiver failure : _betiologies, neurological complications and emerging therapies _c _h[E-Book]
264		1	_aNew York : _bNova Biomedical, _c[2013]
300			_a1 online resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aHepatology research and clinical developments
504			_aIncludes bibliographical references and index.
588			_aDescription based on print version record.
505	0		_aLIVER FAILURE: ETIOLOGIES, NEUROLOGICAL COMPLICATIONS AND EMERGING THERAPIES; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Section One; Chapter 1: Hepatic Failure as an Early Complication Following Orthotopic Liver Transplantation; Abstract; Introduction; Primary Complications; Vascular Complications; Immunological Complications; Biliary Complications; Team Experience of Early Post-OLT Complications; Conclusion; References; Chapter 2: Neurological Complications in Liver Transplantation; Abstract; Introduction; Communication Pathways between the Liver and the Brain.
505	8		_aNeurological Complications Associated with Liver TransplantationMajor Neurological Complications after OLT; Immunosuppression Toxicity; Encephalopathy; Seizures; Central Nervous System Infections; Central Pontine Myelinolisis; Cerebrovascular Complications; Neuromuscular Disorders; Minor Neurological Complications after OLT; Differences in Neurological Complications Depend on the Type of Allograft; Neurological Complications in Different Transplant Centers; Conclusion; Acknowledgment; References; Chapter 3: Hepatic Encephalopathy, Cerebral Blood Flow and the Changes in Oxidative Metabolism.
505	8		_aAbstractIntroduction; Liver Failure, Cerebral Blood Flow and Autoregulation; Ammonia and Direct Effects on Cerebral Oxidative Metabolism; Cerebral Amino Acid Transport and Metabolism; Therapeutical Implications and Future Targets; Conclusion; References; Chapter 4: New Insight into the Molecular Roles in the Pathogenesis of HepaticEncephalopathy; Abstract; Introduction; Neurobiology of Liver Failure and Hyperammonemia; Possible Cellular and Molecular Mechanism of HE; Therapeutic Target for Hepatic Encephalopathy; In Vivo and In Vitro Models for Study of Chronic Liver Impairment.
505	8		_aConclusion and Future DirectionsReferences; Chapter 5: Disordered Central Neural Regulation of the Cardiovascular Systemin Liver Failure; Abstract; Introduction; Brainstem/Hypothalamic Neuronal Activation in Liver Disease; Neural Activation and Portal Hypertension: Chicken or Egg?; Conclusion and Future Perspectives; References; Chapter 6: Hepatic Microcirculation in Chronic Liver Disease; Abstract; References; Chapter 7: Astrocytes and Endothelial Cells Behavior Found in Brain Hippocampus in Prehepatic Portal Hypertensive Rats; Abstract; Introduction; Portal Hypertension; The Hippocampus.
505	8		_aGlial CellsEndothelial Cells; Hepatic Encephalopathy; Material and Methods; Results; Discussion; References; Section Two; Chapter 8: Direct Antiviral Agents for Chronic Viral Hepatitis Treatment; Abstract; Introduction; Direct Antiviral Agents for Chronic B Hepatitis Treatment; New Antiviral Drugs for Chronic Hepatits C Treatment; Conclusion; References; Chapter 9: Emergent Therapies in Acute Liver Failure; Abstract; Introduction; Auxiliary Liver Transplantation (ALT); Extracorporeal Liver Assist Devices; Hepatocyte Transplantation; New Perspectives; Acknowledgments; References.
520			_aThe recently published article ""The Burden of Liver Disease in Europe: A Review of Available Epidemiological Data"" provides a few figures on the enormous problem that liver disease poses for Europeans. Liver disease is estimated to cause 170,000 deaths annually in Europe, 47,000 of which are attributed to liver cancer; 0.5%-0.7% of the European population is affected by chronic hepatitis B; and prevalence rates of hepatitis C virus (HCV) infection in the last decade in the European population ranged from 0.13 to 3.26%. These HCV-infected populations will develop complications in the years to.
590			_aMaster record variable field(s) change: 050, 082
650		0	_aLiver _xFailure.
650		0	_aLiver _xFailure _xTreatment.
650		0	_aLiver _xDiseases.
650		0	_aBiliary tract _xDiseases.
700	1		_aPeralta, Carmen, _eeditor.
700	1		_aFontana, Luis, _eeditor.
830		0	_aHepatology research and clinical developments series.
856			_u#gotoholdings _yAccess resource
938			_aEBSCOhost _bEBSC _n710361
942			_n0
994			_a92 _bN$T
999			_c91677 _d91677